| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.KINT.2016.03.040 |
| P698 | PubMed publication ID | 27282936 |
| P2093 | author name string | Qin Zhou | |
| Xueqing Yu | |||
| Gloria Del Peso | |||
| Rafael Selgas | |||
| M-Auxiliadora Bajo | |||
| P2860 | cites work | TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis | Q82794174 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal dialysis | Q202301 |
| peritoneal dialysis | Q1756474 | ||
| P304 | page(s) | 515-524 | |
| P577 | publication date | 2016-06-07 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Preventing peritoneal membrane fibrosis in peritoneal dialysis patients | |
| P478 | volume | 90 |
| Q91813275 | Activation of General Control Nonderepressible-2 Kinase Ameliorates Glucotoxicity in Human Peritoneal Mesothelial Cells, Preserves Their Integrity, and Prevents Mesothelial to Mesenchymal Transition |
| Q33724949 | Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis |
| Q96231292 | Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5 |
| Q61450664 | Biocompatible Peritoneal Dialysis: The Target Is Still Way Off |
| Q38678051 | CD147 expression in peritoneal injury |
| Q91968506 | Crucial Role of NLRP3 Inflammasome in the Development of Peritoneal Dialysis-related Peritoneal Fibrosis |
| Q49808713 | Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation |
| Q47160299 | Dissolved molecular hydrogen (H2) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity |
| Q93111087 | Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose‑based peritoneal dialysis fluids |
| Q90470242 | Effects of long-term treatment with low-GDP, pH-neutral solutions on peritoneal membranes in peritoneal dialysis patients |
| Q90451156 | Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis |
| Q46525336 | Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis |
| Q97529188 | Hypochlorite-induced porcine model of peritoneal fibrosis through the activation of IL1β-CX3CL1-TGFβ1 signal axis |
| Q33906324 | Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis |
| Q54972703 | Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis. |
| Q99412452 | Peritoneal dialysate-range hypertonic glucose promotes T cell IL-17 production that induces mesothelial inflammation |
| Q92468986 | Protective effects and mechanisms of omega-3 polyunsaturated fatty acid on intestinal injury and macrophage polarization in peritoneal dialysis rats |
| Q64085180 | Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum |
| Q92617913 | Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients |
| Q58710420 | Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis |
| Q92522559 | ST2 blockade mitigates peritoneal fibrosis induced by TGF-β and high glucose |
| Q47096709 | Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition |
| Q49401359 | The Complement System in Dialysis: A Forgotten Story? |
| Q99637164 | Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells |
Search more.